Tas Med (India) Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 23-10-2024
- Paid Up Capital ₹ 2.74 M
as on 23-10-2024
- Company Age 31 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.71 Cr
as on 23-10-2024
- Satisfied Charges ₹ 2.19 Cr
as on 23-10-2024
- Revenue 10.22%
(FY 2023)
- Profit 18.30%
(FY 2023)
- Ebitda 14.79%
(FY 2023)
- Net Worth 36.90%
(FY 2023)
- Total Assets 28.69%
(FY 2023)
About Tas Med (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.74 M.
The company currently has active open charges totaling ₹15.71 Cr. The company has closed loans amounting to ₹2.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harjinder Singh and Kuljeet Kaur serve as directors at the Company.
- CIN/LLPIN
U24231CH1993PTC014002
- Company No.
014002
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Tas Med (India) Private Limited offer?
Tas Med (India) Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Common Disease Medicines, Pharmaceutical Capsules, Antiepileptic Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Cosmetics, Hair & Beauty Products, Hair Care Cosmetics, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Tas Med (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harjinder Singh  | Director | 15-Dec-1993 | Current |
| Kuljeet Kaur | Director | 07-Feb-2012 | Current |
Financial Performance of Tas Med (India).
Tas Med (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.22% increase. The company also saw a substantial improvement in profitability, with a 18.3% increase in profit. The company's net worth Soared by an impressive increase of 36.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tas Med (India)?
In 2023, Tas Med (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avenue Remedies India Private LimitedActive 20 years 18 daysHarjinder Singh and Kuljeet Kaur are mutual person
- Tas Med Laboratories Indai Pvt LtdActive 18 years 8 months
Harjinder Singh and Kuljeet Kaur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 May 2024 | ₹0.81 M | Open |
Hdfc Bank Limited Creation Date: 24 Aug 2022 | ₹4.04 M | Open |
Standard Chartered Bank Creation Date: 28 Jan 2022 | ₹3.91 M | Open |
How Many Employees Work at Tas Med (India)?
Tas Med (India) has a workforce of 809 employees as of Aug 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tas Med (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tas Med (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
